HkeyBio Launches NHP Fast-PoC Program for Low-Cost Cynomolgus PK/PD Validation
- HkeyBio introduced NHP Fast-PoC, a streamlined preclinical service using small cynomolgus monkey cohorts to validate pharmacokinetics, target engagement, and developability at lower cost and faster timelines than conventional full-scale studies.
- The program targets early-stage biotech firms in capital-constrained markets, answering four critical R&D questions before IND commitment: systemic circulation, target engagement, occupancy duration, and biomarker response.
- HkeyBio operates dedicated NHP facilities in Suzhou and Guangxi with 50+ autoimmune/allergy disease models and has supported 500+ IND submissions for immune-modulating biologics globally.
Operational Impact
HkeyBio's Fast-PoC offering reduces preclinical validation costs and timelines for biotech sponsors evaluating immune-modulating candidates, enabling earlier go/no-go decisions and potentially increasing demand for streamlined NHP services among capital-constrained development teams.
Source: PR Newswire pharma category RSS
References
- PR Newswire pharma category RSS — [HkeyBio Launches NHP Fast-PoC Program for Low-Cost Cynomolgus PK/PD Validation](https://www.prnewswire.com/news-releases/hkeybio-launches-nhp-fast-poc-program-to-deliver-low-cost-cyno-pkpd-and-developability-data-amid-rising-nhp-prices-302796134.html)